← Back
$AKTX All transactions

Akari Therapeutics Plc

▲ BUY
7 / 10

Conviction

$ Value

Shares

247,462

Price

Filed

Dec 18

Why this score? (7/10)
  • Open market buy (+3)
  • Director (+1)
  • Cluster: 8 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Patel Sandip I

Title

CIK

0001843601

Roles

Director

Transaction Details

Transaction Date

2025-12-16

Code

P

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

247,462

Footnotes

Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. | On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 247,462 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 247,462 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. | The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. | The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. | On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 154,664 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 160,958 ADSs (the "Note Exchange Unregistered Warrants"). | The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. | Conversion Exercise Price of Security is $0.00001

Filing Info

Accession No.

0001493152-25-028421

Form Type

4

Issuer CIK

0001541157

Patel Sandip I's History

Date Ticker Type Value
2025-12-16 AKTX
2025-12-16 AKTX $100K
2025-12-16 AKTX
2025-12-16 AKTX $62K
2025-03-06 AKTX A $50K
2025-03-06 AKTX A $50K
2025-03-06 AKTX A $50K

Other Insiders at AKTX (90d)

Insider Bought Sold Last
Neal James R $2K 2025-12-16